Correlation Between Moleculin Biotech and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Pfizer Inc, you can compare the effects of market volatilities on Moleculin Biotech and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Pfizer.

Diversification Opportunities for Moleculin Biotech and Pfizer

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Moleculin and Pfizer is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Pfizer go up and down completely randomly.

Pair Corralation between Moleculin Biotech and Pfizer

Given the investment horizon of 90 days Moleculin Biotech is expected to under-perform the Pfizer. In addition to that, Moleculin Biotech is 3.84 times more volatile than Pfizer Inc. It trades about -0.04 of its total potential returns per unit of risk. Pfizer Inc is currently generating about -0.07 per unit of volatility. If you would invest  4,663  in Pfizer Inc on August 30, 2024 and sell it today you would lose (2,080) from holding Pfizer Inc or give up 44.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Moleculin Biotech  vs.  Pfizer Inc

 Performance 
       Timeline  
Moleculin Biotech 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Moleculin Biotech and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Moleculin Biotech and Pfizer

The main advantage of trading using opposite Moleculin Biotech and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Moleculin Biotech and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data